Showing results (161-170 of 169) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 169 results.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Molecular basis of nick ligation in the nucleosome by DNA Ligase IIIαDaniel J Boesch, Nadia I Martin, Chantal A Kontor, et al.
The Journal of Physical Chemistry. B|May 10, 2007
Crystal and electronic structures of magnesium(II), copper(II), and mixed magnesium(II)-copper(II) complexes of the quinoline half of styrylquinoline-type HIV-1 integrase inhibitorsB Courcot, D Firley, B Fraisse, et al.
Scientific Reports|January 19, 2016
Anti-nociceptive effect of Faecalibacterium prausnitzii in non-inflammatory IBS-like modelsS Miquel, R Martín, A Lashermes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 14, 2006
Intra-arterial hepatic fotemustine for the treatment of liver metastases from uveal melanoma: experience in 101 patientsS Peters, V Voelter, L Zografos, et al.
Science (New York, N.Y.)|April 30, 2011
Imaging doped holes in a cuprate superconductor with high-resolution Compton scatteringY Sakurai, M Itou, B Barbiellini, et al.
Breast Cancer Research and Treatment|February 9, 2017
Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer: a randomized Phase I studyM Higgins, G Curigliano, V Dieras, et al.
Brain, Behavior, and Immunity|June 4, 2018
Early life stress in mice is a suitable model for Irritable Bowel Syndrome but does not predispose to colitis nor increase susceptibility to enteric infectionsA Riba, M Olier, S Lacroix-Lamandé, et al.
Nature Medicine|July 14, 1998
Limited CD4+ T-cell renewal in early HIV-1 infection: effect of highly active antiretroviral therapyS Fleury, R J de Boer, G P Rizzardi, et al.
ESMO Open|November 16, 2016
Safety and immunogenicity of the PRAME cancer immunotherapeutic in metastatic melanoma: results of a phase I dose escalation studyR Gutzmer, L Rivoltini, E Levchenko, et al.
Pageof 17